MedTrace Logo

Methadone in Pediatric and Adult Sickle Cell Patients

NCT00761085 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2020-01-22

Study results available
· View outcomes & findings →

Summary

To determine the pharmacokinetics of methadone in children and adults with SCD who are experiencing a painful episode.

Conditions

Interventions

DRUG

Morphine

Standard of care for pain management of acute episode of pain

DRUG

Methadone

Compare to standard of care for pain management of acute episode of pain

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Evan D Kharasch, MD, PhD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-01
Primary Completion
2010-11-07
Completion
2010-11-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00761085 on ClinicalTrials.gov